...
RIGLSMALL

Rigel Pharmaceuticals, Inc.

HealthcareBiotechnology
$34.74
$0.01(-2.72%)
52W$15.50
$52.24
FinancialsValuationvs ARGX
Updated Mar 2, 12:00 AM
RSI49
RS Rating61/99
Beta0.86
Volatility70%
F-Score7/9
Mkt Cap$615M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Rigel Pharmaceuticals, Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is moderate (RS Rating: 61), indicating performance broadly in line with the market. Earnings growth of 108% provides fundamental context to the price action. Investors should exercise caution due to high volatility (70% annualized), which requires wider risk management.

Relative Strength
61
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.86
vs S&P 500
DEFENSIVE
52W Position
52%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$38.21
50 SMA > 100 SMA$37.77
100 SMA > 150 SMA$36.38
150 SMA > 200 SMA$32.20

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$34.91-0.48%BELOW
50 SMA$38.21-9.08%BELOW
100 SMA$37.77-8.02%BELOW
150 SMA$36.38-4.52%BELOW
200 SMA$32.20+7.87%ABOVE

Price Performance

1D-2.7%
1W+1.4%
1M-1.4%
3M-31.2%
6M-11.6%
YTD-16.9%
1Y+50.7%
3Y+32.0%
52-Week Trading Range52% from low
$34.74
52W Low$15.50
52W High$52.24

Technical Indicators

RSI (14)NEUTRAL
48.7
305070
VCP ScoreCOOL
4/10
Base depth: 48.7%

Risk Profile

Beta
0.86
52W Vol
70%
ATR
$1.48
Max DD (1Y)
-36%

Volume Analysis

Today
34
50D Avg
347.4K
Vol Ratio
0.00x
Liquidity
MODERATE

Earnings Momentum

Q4'24+1796%
$0.80
Q1'25+234%
$0.63
Q2'25+5567%
$3.28
Q3'25+108%
$1.46
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+36.05%
5 Years:+24.77%
3 Years:+6.30%
TTM:+79.13%

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:—
TTM:+28.06%

Stock Price CAGR

10 Years:+4.35%
5 Years:-4.92%
3 Years:+32.01%
1 Year:+50.65%

Return on Equity

10Y Avg:-75.6%
5Y Avg:-72.7%
3Y Avg:-83.6%
Last Year:96.3%

Key Metrics

Market Cap$615M
Gross Margin89.6%
Net Margin9.8%
Piotroski F-Score7/9

More RIGL Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

RIGL vs ARGXARGXCANFAKTXABVX

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 61 meansRIGL outperformed 61% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.86 means 14% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 7/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 4/10 with COOL status.

Frequently Asked Questions

Is RIGL in an uptrend right now?

RIGL has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is RIGL overbought or oversold?

RIGL's RSI (14) is 49. The stock is in neutral territory, neither overbought nor oversold.

Is RIGL outperforming the market?

RIGL has a Relative Strength (RS) Rating of 61 out of 99. RIGL is performing about average compared to the market.

Where is RIGL in its 52-week range?

RIGL is trading at $34.74, which is 67% of its 52-week high ($52.24) and 52% above its 52-week low ($15.50).

How volatile is RIGL?

RIGL has a Beta of 0.86 and 52-week volatility of 70%. It's less volatile than the S&P 500 - generally more stable.